Epigenetic Gene Regulation in Plasma Cells
Overview
General Surgery
Affiliations
Humoral immunity provides protection from pathogenic infection and is mediated by antibodies following the differentiation of naive B cells (nBs) to antibody-secreting cells (ASCs). This process requires substantial epigenetic and transcriptional rewiring to ultimately repress the nB program and replace it with one conducive to ASC physiology and function. Notably, these reprogramming events occur within the framework of cell division. Efforts to understand the relationship of cell division with reprogramming and ASC differentiation in vivo have uncovered the timing and scope of reprogramming, as well as key factors that influence these events. Herein, we discuss the unique physiology of ASC and how nBs undergo epigenetic and genome architectural reorganization to acquire the necessary functions to support antibody production. We also discuss the stage-wise manner in which reprogramming occurs across cell divisions and how key molecular determinants can influence B cell fate outcomes.
The monitoring of B lymphocytes in non-lymphoma patients following rituximab treatment.
Dong L, Yan L, Li Y, Li M, Feng W, Li X Front Immunol. 2024; 15:1513303.
PMID: 39654895 PMC: 11625799. DOI: 10.3389/fimmu.2024.1513303.
Plasma cell differentiation is regulated by the expression of histone variant H3.3.
Saito Y, Harada A, Ushijima M, Tanaka K, Higuchi R, Baba A Nat Commun. 2024; 15(1):5004.
PMID: 38902223 PMC: 11190180. DOI: 10.1038/s41467-024-49375-x.
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture.
Nguyen D, Saney C, Hentenaar I, Cabrera-Mora M, Capric V, Woodruff M Sci Rep. 2024; 14(1):3616.
PMID: 38350990 PMC: 10864258. DOI: 10.1038/s41598-024-53977-2.
Neri P, Barwick B, Jung D, Patton J, Maity R, Tagoug I Blood Cancer Discov. 2023; 5(1):56-73.
PMID: 37934799 PMC: 10772538. DOI: 10.1158/2643-3230.BCD-23-0061.
A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation.
Xiong E, Popp O, Salomon C, Mertins P, Kocks C, Rajewsky K Front Immunol. 2023; 13:1083119.
PMID: 36685499 PMC: 9849354. DOI: 10.3389/fimmu.2022.1083119.